University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Award News

Congratulations to the recent recipients of RAP and ACS funding!

RAP Awardees - Fall 2017 Cycle

  • Diane Barber, PhD
    "New Direction to Identify Regulators of Lysosome pH Dynamics"
  • Joseph Costello, PhD
    "In vivo regulators of TERT promoter mutant glioblastoma"
  • Michelle Hermiston, MD, PhD
    "Interrogating the mechanisms of il7-induced glucocorticoid resistance in t-cell acute lymphoblastic leukemia"
  • Kimberly Kirkwood, MD
    "Population-based Analysis of Neoplastic Changes in Cystic lesions of the Pancreas (PANC Cyst) Registry"
  • Grace Lin, MD
    "Identification and Predictors of Use of Limited Clinical Utility Therapies for Metastatic Colorectal Cancer"
  • Hilde Schjerven, PhD
    "Role of recurrent Ikaros mutations in acute myeloid leukemia (AML)"
  • Carolyn Seib, MD
    "Postoperative cognitive dysfunction in elderly patients undergoing surgery for thyroid cancer"
  • Youngho Seo, PhD
    "Next-Generation Small Animal PET/CT"
  • Tara Sigdel, PhD
    "Identification and validation of alloepitopes in kidney transplantation. A step forward to precision medicine in organ transplantation"
  • Francis Szoka, PhD
    "Hymecromone prodrugs to inhibit hyaluronan synthesis in the tumor matrix"
  • Luika Timmerman, PhD
    "Cross format analysis of xCT expression and function in breast and GI tract carcinomas"
  • David Toczyski, PhD
    "Exploiting camptothecin sensitivity to target Indisulam-resistant tumor cells"
  • Henry VanBrocklin, PhD
    "First-in-human evaluation of tumor necrosis factor alpha molecular imaging in patients with rheumatoid arthritis: advancing precision medicine"
  • Rong Wang, PhD
    "Molecular Therapy for Critical Limb Ischemia"

About the RAP Awards

The Resource Allocation Program (RAP) is a campus-wide program whose aim is to coordinate intramural research funding opportunities for the UCSF community. Through RAP, the Cancer Center and other UCSF agencies provide seed funding to encourage clinical investigators, especially those at the beginning of their career, to initiate promising projects that may enable them to compete successfully for national research grants. Targeted areas are innovative pilot and phase I/II studies and other projects in clinical, health policy, health services, and psychosocial and behavioral research.

American Cancer Society Awardees

  • Collin Blakely, MD, PhD
    "Defining molecular determinants of response to the MEK inhibitor trametinib in NF1-mutant NSCLC"
  • Stephen Floor, PhD
    "Oncogenic reprogramming of protein translation by DDX3 inactivation"
  • Benjamin Huang, MD
    "Response and resistance to bromodomain inhibition in acute myeloid leukemia"
  • Amit Sabnis, MD
    "Defining the biologic basis of targetable protein chaperone addiction in rhabdomyosarcoma"

About the ACS Individual Research Awards

This program is to make seed funding available to encourage junior investigators to initiate promising new projects in cancer-related research that may enable them to compete successfully for national research grants. Targeted are projects in basic, clinical, health policy, health services, psychosocial and behavioral, epidemiologic, and control research that seek to answer fundamental questions about the development and nature of cancer; have direct application to the prevention, diagnosis, and treatment of cancer; relate to health policy or delivery of cancer care; investigate the psychosocial and behavioral impact of cancer; or study the circumstances under which cancer occurs in populations. Learn more.

Updated February 2018